573P M9140, an anti-CEACAM5 antibody drug conjugate (ADC), in patients with metastatic colorectal cancer (mCRC): Updated results from a phase I trialdoi:10.1016/j.annonc.2024.08.642V. BoniS. KopetzK. KatoK. RaghavM. VieitoA.G. Pallis...
SGN-CEACAM5C SGN-PDL1V SHR-A1201 Sirtratumab vedotin | ASG-15ME SKB315 SNG-8023 ADC Sofituzumab vedotin | Anti-MUC16 ADC | RG7458 | DMUC5754A SOT102 | SO-N102 ST1 ST8176AA1 STI-6129 | LNDS1001 | CD38-077 STRO-001 (Anti-CD74-ADC) STRO-003 STRO-004 Sudocetaxel Zendusortide...
hMN14, IMMU-130, hMN-14-SN-38, hMN-14-SN-38 ADC, hMN14-CL-SN-38, Labetuzumab Govitecan, CAS: 219649-07-7 Note For research use only. Not suitable for clinical or therapeutic use. 关键字:labetuzumab;拉贝珠单抗;219649-07-7;CEA, CD66e;CEACAM5; ...
Thermo-life PA532014 ANTI-CEACAM21 EA ￥3,478.00 EA Thermo-life PA532016 ANTI-BRMS1L EA ￥3,478.00 EA Thermo-life PA532019 ANTI-TBC1D22A EA ￥3,478.00 EA Thermo-life PA532021 ANTI-DOC1 EA ￥3,478.00 EA Thermo-life PA532022 ANTI-TTLL4 EA ￥3,478.00 EA Thermo-life PA532023 ANTI-TM...
Anti-CEACAM1/CD66aAntibody|MedChemExpress(MCE)货期是多久? Anti-CEACAM1/CD66aAntibody|MedChemExpress(MCE)使用注意事项? 店铺推荐 JDB175 | MedChemExpress (MCE) 面议咨询 UNC8153 TFA | MedChemExpress (MCE) ￥1500~5900~9500咨询 CYP19A1/CYP11B2-IN-1 | MedChemExpress (MCE) ...
December 28, 2022Djou0 Comments Promoted Lab recombinants Our used TESTs in Pubmed. Read more Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells.Mono(2-ethylhexyl) phthalate accelerates early fo...
Rs-7999R CEACAM19/CEAL1??癌胚抗原相关细胞粘附分子19抗体 规格0.2ml和0.1ml,多数抗体有库存antibody促销Rs-8012R ADCK5??ADCK5蛋白抗体 规格0.2ml和0.1ml,多数抗体有库存antibody促销Rs-8013R ITGB1BP2/CHORDC3??整合素β1结合蛋白2抗体 规格0.2ml和0.1ml,多数抗体有库存antibody促销Rs-8014R CLDND2??膜...
(CEACAM1), high mobility group box protein 1 (HMGB1), and phosphatidylserine have been identified as ligands of TIM-3 but none of them seems exclusive (Fig.2). Galectin-9 and CEACAM1 suppress anti-tumor immunity by ligating TIM-3 to inhibit type 1 immunity.60,61Expression of intracellular...
Activity of IMMU-130 anti-CEACAM5-SN-38 antibody-drug conjugate (ADC) on metastatic colorectal cancer (mCRC) having relapsed after CPT-11: Phase I study. Paper presented at: 2014 Annual Meeting of the American Society of Clinical Oncology; Chicago, IL. 56. Starodub A, Ocean AJ, G...
Govindan et al., “IMMU-130, a unique antibody-drug conjugate (ADC) of SN-38 targeting CEACAM5 antigen: Preclinical basis for clinical activity in metastatic colorectal cancer (mCRC)”, J Clin Oncol 33, 2015 (suppl 3; abstr 625), Retrieved from http://meetinglibrary.asco.org/content/139...